Перегляд за автором "Bilko, N.M."

Результати 1-3 з 3

Circulating hematopoietic progenitor cells in patients affected by chornobyl accident

Bilko, N.M.; Dyagil, I.S.; Russu, I.Z.; Bilko, D.I. (Experimental Oncology, 2016)

High radiation sensitivity of stem cells and their ability to accumulate sublethal radiation damage provides the basis for investigation of hematopoietic progenitors using in vivo culture methodology. Unique samples of ...
Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors

Zhaleiko, I.O.; Perekhrestenko, T.P.; Bilko, D.I.; Dyagil, I.S.; Bilko, N.M. (Experimental Oncology, 2014)

Background: Targeted therapy drugs, including imatinib, are used for inhibiting the marker oncoprotein of chronic myeloid leukemia — BCR-ABL tyrosine kinase. However, in some patients the drug resistance can emerge too ...
Differentiation of pluripotent stem cells into cardyomyocytes is influenced by size of embryoid bodies

Budash, G.V.; Bilko, D.I.; Bilko, N.M. (Вiopolymers and Cell, 2016)

Aim. To find the relationship between the size of embryoid bodies and the efficiency of pluripotent stem cells differentiation into cardiomyocytes. Methods. Transgenic murine iPSC line AT25 and D3 ESC line αPIG (clone 44) ...

Результати 1-3 з 3

Пошук